Novo Nordisk hits a 4-year low, just days after rival Eli Lilly hits a $1T market cap milestone.Plus, some former high-flyers trading more down to earth. Is now the time to get in?  And, two unlikely names dominating the AI narrative now. Hosted by Simplecast, an AdsWizz company. See <a href="https://pcm.adswizz.com">pcm.adswizz.com</a> for information about our collection and use of personal data for advertising.

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Novo Nosedives, New AI Darlings & Buy the Former High-Flyers? 11/24/25

The Exchange

AI Chapters

AI Insights

Reviews